Home  
  Our Team  
  Patient Info  
  Services  
   
  Pay My Bill  
  Contact Us  

News for Healthier Living

ESMO 2026: New Targeted Therapy Improved Survival for Patients with KRAS-Mutated Lung Cancer

Patients with previously treated advanced KRAS G12C-mutant non-small cell lung cancer (NSCLC) lived significantly longer and saw improved disease control when treated with the next-generation KRAS targeted therapy divarasib, according to researchers from The University of Texas MD Anderson Cancer Center.

October 25, 2026


October 26 2026

October 25 2026

October 24 2026

October 23 2026

October 22 2026

October 21 2026

October 20 2026

October 19 2026

October 18 2026

October 17 2026

October 16 2026

October 15 2026

October 14 2026

October 13 2026

October 12 2026